Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes

Author：                                    

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.1, 2012-01, pp. : 63-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican3derived peptide

By                

International Journal of Oncology, Vol. 43, Iss. 4, 2013-01 ,pp. : 1019-1026

Spandidos Publications

Access to resources Recommend Favorite

Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 28-36

Spandidos Publications

Access to resources Recommend Favorite

Radiofrequency ablation for hepatocellular carcinoma

By Nishikawa Hiroki   Kimura Toru   Kita Ryuichi   Osaki Yukio  

International Journal of Hyperthermia, Vol. 29, Iss. 6, 2013-09 ,pp. : 558-568

Informa Healthcare

Access to resources Recommend Favorite

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide

By              

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite

Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 6, 2011-07 ,pp. : 543-548

Bentham Science Publishers

Access to resources Recommend Favorite